Czech generics company Zentiva Group has begun bulking up on acquisitions and says it is on the lookout for more opportunities as it seeks to become “the champion of generics in Europe” under its new owner, private-equity giant Advent International.
Zentiva, which has a strong presence in Eastern Europe, particularly in the Czech Republic, Slovakia and Romania, announced it is acquiring UK company Creo Pharmaceuticals from Amneal Pharmaceuticals, a New
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?